Peter Thiel, Getty (Photographer: Kiyoshi Ota/Bloomberg)
Peter Thiel's psychedelics-focused ATAI acquires majority stake in Recognify and its lead schizophrenia candidate
Billionaire Peter Thiel has made significant and sometimes controversial pushes into life sciences over the past few years, and one of his startups out …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.